Zvi Ackerman

Prof. Dr. Zvi Ackerman

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2005 in Hypertension
Verified
Journal Article
Closed access
PDF file
ZAZvi Ackerman
Zvi Ackerman
MOMor Oron-Herman
Mor Oron-Herman
MGMaria Grozovski
Maria Grozovski
TRTalma Rosenthal
Talma Rosenthal
OPOrit Pappo
Orit Pappo
BSBen-Ami Sela
Ben-Ami Sela
The most known risk factor for nonalcoholic fatty liver disease (NAFLD) is the metabolic syndrome. In this study, we characterized changes in liver pathology, hepatic lipid composition, and hepatic iron concentration (HIC) occurring in rats given fructose-enriched diet (FED), with and without therapeutic maneuvers to reduce blood pressure and plasma triglycerides. Rats were given FED or standard rat chow for 5 weeks. Rats on FED were divided into 4 groups: receiving amlodipine (15 mg/kg per day), captopril (90 mg/kg per day), bezafibrate (10 mg/kg per day) in the last 2 weeks, or a control group that received FED only. FED rats had hepatic macrovesicular and microvesicular fat deposits develop, with increase in hepatic triglycerides (+198%) and hepatic cholesterol (+89%), but a decrease in hepatic phospholipids (−36%), hypertriglyceridemia (+223%), and hypertension (+15%), without increase in HIC. Amlodipine reduced blood pressure (−18%), plasma triglycerides (−12%), but there was no change in hepatic triglycerides and phospholipids concentrations. Captopril reduced blood pressure (−24%), plasma triglycerides (−36%), hepatic triglycerides (−51%), and hepatic macrovesicular fat (−51%), but increased HIC (+23%), with a borderline increase in hepatic fibrosis. Bezafibrate reduced plasma triglycerides (−49%), hepatic triglycerides (−78%), hepatic macrovesicular fat (−90%), and blood pressure (−11%). We conclude that FED rats can be a suitable model for human NAFLD. Drugs administered to treat various aspects of the metabolic syndrome could have hepatic effects. An increase in HIC in rats with NAFLD could be associated with increased hepatic fibrosis.

19 January 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
ASAsher Shafrir
Asher Shafrir
MSMichal Shauly-Aharonov
Michal Shauly-Aharonov
LKLior H Katz
Lior H Katz
OPOra Paltiel
Ora Paltiel
YPYishai Pickman
Yishai Pickman
ZAZvi Ackerman
Zvi Ackerman
Background: The success of Helicobacter pylori (H. pylori) eradication depends on several host and treatment factors. Serum vitamin D levels may be associated with H. pylori infection and eradication rates. We investigated the association between vitamin D and H. pylori infection and eradication, using a large electronic database based on medical records from a population-based health maintenance organization. Methods: Data regarding adults who underwent H. pylori testing and had vitamin D measurements within one month of H. pylori testing were collected. H. pylori infection was ascertained using urea breath or stool antigen tests. A negative H. pylori test following a positive result implied eradication. Multivariate regression models were constructed to assess associations between H. pylori infection, eradication, and vitamin D. Results: Among 150,483 members who underwent H. pylori testing from 2009 to 2018, 27,077 (18%) had vitamin D measurements. Vitamin D levels were inversely associated with H. pylori infection, p < 0.001. The odds of a positive H. pylori test were 31% higher among patients with vitamin D levels <20 ng/mL, compared with those with levels ≥20 ng/mL (OR 1.31, 99% CI 1.22–1.4, p < 0.001). Purchase of vitamin D supplements was associated with a negative subsequent H. pylori test (p < 0.001). Mean vitamin D levels were moderately higher in those with successful vs. failed H. pylori eradication (19.34 ± 9.55 vs. 18.64 ± 9.61, p < 0.001). Conclusions: Vitamin D levels are associated with H. pylori infection. Increased vitamin D levels are associated with successful H. pylori eradication. Vitamin D may have a role in H. pylori eradication.

14 July 2010 in Basic & Clinical Pharmacology & Toxicology
Verified
Journal Article
Closed access
PDF file
ZAZvi Ackerman
Zvi Ackerman
MOMor Oron‐Herman
Mor Oron‐Herman
OPOrit Pappo
Orit Pappo
EPEdna Peleg
Edna Peleg
RSRifaat Safadi
Rifaat Safadi
MGMaria Grozovski
Maria Grozovski

1 April 2002 in Liver International
Verified
Journal Article
Closed access
PDF file
ZAZvi Ackerman
Zvi Ackerman
MWMiron Weinreb
Miron Weinreb
GAGail Amir
Gail Amir
RPRivka D Pollak
Rivka D Pollak

22 August 2007 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
ZAZvi Ackerman
Zvi Ackerman
MOMor Oron-Herman
Mor Oron-Herman
TRTalma Rosenthal
Talma Rosenthal
OPOrit Pappo
Orit Pappo
GLGabriela Link
Gabriela Link
MGMaria Grozovski
Maria Grozovski

28 August 2014 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
ZAZvi Ackerman
Zvi Ackerman
OPOrit Pappo
Orit Pappo
GLGabriela Link
Gabriela Link
MGMaya Glazer
Maya Glazer
MGMaria Grozovski
Maria Grozovski